companydata.dkcompanydata.dk

GSK Invest ApS: Financial statements 2022

CVR: 40362541

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

GSK Invest ApS (CVR 40362541) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -11,632 and a net result of DKK 1,074,648 compared with DKK 924,236 the year before. Equity in the 2022 report amounted to DKK 4,177,730. The solvency ratio was 94.6%.

Revenue
DKK 0
Gross Profit
DKK -11,632
Profit/Loss
DKK 1,074,648
Equity
DKK 4,177,730
Total Assets
DKK 4,415,392

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20220-12K1.1M4.2M-
20210-11K924K3.1M-
2020--69K445K2.2M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on GSK Invest ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

GSK Invest ApS: The 2021 annual report is outJun 27, 2022

GSK Invest ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK 924,236.

GSK Invest ApS appoints new auditorJun 24, 2022

As of June 24, 2022, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of GSK Invest ApS.

Auditor steps down at GSK Invest ApSJun 24, 2022

As of June 24, 2022, DR CPH A/S has stepped down as auditor of GSK Invest ApS.

About GSK Invest ApS

GSK Invest ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Gorm Schmidt Knudsen. The company is owned by Gorm Schmidt Knudsen. The company has 1 employee (2021). In 2025, the company reported a gross profit of DKK -14,099 and a net result of DKK 938,720 compared with DKK 1,055,884 the year before. Equity in the 2025 report amounted to DKK 6,526,830.

Source: annual report 2025, Danish Business Authority

Other financial years